A big Novartis deal turns on a quirk of how drugs are paid for in the U.S.: Insurers have less control over drugs given in hospitals than pharmacies
Novartis AG Chief Executive Vas Narasimhan has spent the past two years buying up cutting-edge science. His latest deal is a high-stakes bet that the Swiss health-care giant will succeed where many have struggled: launching a new heart drug.
Cardiovascular diseases are the number-one cause of death in the U.S., but new drugs for conditions like high cholesterol and heart failure have proven tough to sell. They compete with a bevy of older, cheaper drugs, and cardiologists typically want to see evidence that patients benefit...
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Turkey signs maritime boundaries deal with Libya amid exploration rowLibya's internationally recognized government and Turkey have signed an agr...
Leer más »
Trump says the US-China trade deal is in its 'final throes' — but analysts are skeptical'I'm holding it up because it's got to be a good deal,' Trump later said to former Fox News host Bill O'Reilly.
Leer más »
Exclusive: South Korea, Japan set to back air traffic deal after near missesSouth Korea and Japan are setting aside historical grievances to redraw responsi...
Leer más »
Iran says it’s staying within the ‘general framework’ of the nuclear dealIn a recent statement to the International Atomic Energy Agency (IAEA), Iran has reiterated its commitment to the nuclear deal while Washington continues to sabotage the landmark agreement.
Leer más »
EU states reach deal to ease banks' bad loan recoveryEuropean Union governments reached a deal on Wednesday on new rules to facilitat...
Leer más »